financetom
Business
financetom
/
Business
/
Chile's Codelco posts 2023 gross profit of $3.12 billion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Chile's Codelco posts 2023 gross profit of $3.12 billion
Mar 28, 2024 5:37 PM

SANTIAGO, March 28 (Reuters) - Chilean copper giant

Codelco reported gross profit of $3.12 billion for

2023, the state-owned producer said in a filing on Thursday.

Codelco, the world's top copper miner, posted production

of 1.325 million metric tonnes for the year, according to the

filing, compared to 1.446 million tons in 2022.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
The Marygold Raises $4.4 Million in Private Placement With Streeterville Capital
The Marygold Raises $4.4 Million in Private Placement With Streeterville Capital
Sep 26, 2024
05:08 PM EDT, 09/24/2024 (MT Newswires) -- The Marygold ( MGLD ) said Tuesday it raised about $4.4 million in funding as part of a $6.6 million private placement with Streeterville Capital. The investment is through the sale of a secure promissory note of the company, The Marygold ( MGLD ) added. Net proceeds from the private placement will be...
Distribution Solutions Group's Gexpro Services to Buy Tech-Component Resources
Distribution Solutions Group's Gexpro Services to Buy Tech-Component Resources
Sep 26, 2024
05:10 PM EDT, 09/24/2024 (MT Newswires) -- Distribution Solutions Group ( DSGR ) said Tuesday that its operating company Gexpro Services agreed to acquire Tech-Component Resources, a Southeast Asian distributor of fasteners, mechanical parts and other industrial products. The deal will be financed using current cash reserves and is slated to close in Q4, according to Distribution Solutions ( DSGR...
Amgen's experimental skin disease drug meets main goals in study
Amgen's experimental skin disease drug meets main goals in study
Sep 26, 2024
Sept 24 (Reuters) - Amgen ( AMGN ) said on Tuesday its experimental drug, rocatinlimab, met the main goals in a late stage study testing it as a treatment for an inflammatory skin condition known as atopic dermatitis. ...
Progress Software Stock Jumps On Q3 Earnings: Revenue Beat, EPS Beat, Raised Guidance And More
Progress Software Stock Jumps On Q3 Earnings: Revenue Beat, EPS Beat, Raised Guidance And More
Sep 26, 2024
Progress Software Corp ( PRGS ) shares are trading higher in Tuesday’s after-hours session after the company reported better-than-expected financial results for the third quarter. Q3 Revenue: $178.69 million, versus estimates of $175.94 million Q3 EPS: $1.26, versus estimates of $1.14 Total revenue was up 2% on a year-over-year basis. Annualized recurring revenue totaled $582 million, “relatively flat” on a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved